Day: January 13, 2026

VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce that it has achieved ECOLOGO® Certification for ULC TS-2723 Responsible Development for Mineral Exploration Industry (the “ECOLOGO® Certification”) from UL Solutions, a global leader in applied safety science. The UL ECOLOGO® Certification is a trusted, third-party certification program that has confirmed Fancamp’s commitment to best practices for responsible development in the mineral exploration industry, whereby the certification and related audit were conducted by UL Solutions. Fancamp has successfully completed the final stage of the certification process, which included comprehensive audit results, use of the UL ECOLOGO® Mark, and registration in SPOT, the...

This news release constitutes a “designated news release” for the purposes of CAPREIT’s prospectus supplement dated May 15, 2025, to its short form base shelf prospectus dated May 15, 2025. Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (TSX:CAR.UN) (“CAPREIT”) announced today that Mr. Julian Schonfeldt will be leaving CAPREIT, effective on or about April 30, 2026, to pursue other opportunities after a distinguished career at CAPREIT as Chief Investment Officer. Mr. Schonfeldt joined CAPREIT in 2022 as its inaugural Chief Investment Officer, bringing extensive capital markets expertise from his previous role as Managing Director in the Global Investment Banking Group at RBC Capital Markets....

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 million in aggregate development and sales milestones from Sentynl Therapeutics MIAMI, Jan. 13, 2026 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc. (“Cyprium”), today announced that the U.S. Food and Drug Administration (“FDA”) has approved ZYCUBO® (copper histidinate, formerly known as CUTX-101) for the treatment of Menkes disease in pediatric patients. In December 2023, Sentynl Therapeutics, Inc. (“Sentynl”), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Limited (“Zydus Group”), assumed full responsibility for the development...

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) — Green Shift Commodities Ltd. (TSXV: GCOM and OTCQB: GRCMF), (“Green Shift”, “GCOM” or the “Company”) is announcing that it has granted a total of 3,000,000 stock options (“Options”) to various directors, officers, and consultants of the Company. Each option is exercisable to acquire one Common Share for a period of five years at a price of $.05 per Common Share, with 100% of the Options vesting immediately. The Options are subject to approval of the TSX Venture Exchange. About Green Shift Commodities Ltd. Green Shift Commodities Ltd. is focused on the exploration and development of commodities needed to help decarbonize and meet net-zero goals. The Company is advancing the Armstrong Project, located in the Seymour-Crescent-Falcon lithium belt in northern Ontario, known to host spodumene-bearing...